Immunological treatments for autism

Journal of Autism and Developmental Disorders

Volumn 30, Issue 5, 2000, Pages 475-479

  Gupta, Sudhir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; Immunological abnormalities; Major histocompatibility complex

Indexed keywords

IMMUNE TRANSFER FACTOR; IMMUNOGLOBULIN; PENTOXIFYLLINE;

AUTISM; BEHAVIOR DISORDER; CHILD; CHILDHOOD DISEASE; CYTOKINE PRODUCTION; DEVELOPMENTAL DISORDER; DRUG MECHANISM; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REVIEW;

AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MAJOR HISTOCOMPATIBILITY COMPLEX; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; TRANSFER FACTOR;

EID: 0033745769     PISSN: 01623257     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005568027292     Document Type: Review

References (28)

1. Effect of pentoxifylline and theophylline on neurotransmitter uptake and release by synaptosome-rich homogenates of the rat hypothalamus
2. Dialyzable lymphocyte extract (DIyE) in infantile onset autism: A pilot study
3. Intravenous immunoglobulin therapy in neurological disorders
4. Treatment of children with autism with intravenous immunoglobulin
5. Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics
6. Alterations in Th1 and Th2 subsets of CD4+ and CD8+ T cells in autism
7. Pentoxyfylline: A brief review and rationale for its possible use in the treatment of autism
8. Pentoxifylline review
9. Different effects of methyxanthines on central serotonergic postsynaptic neurons in a mouse behavioral model
10. CD4+ CD45RA+ T lymphocyte deficiency in autistic children: Effect of a pyridoxin-magnesium treatment
11. Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome
12. Functional deficits in autistic disorder: Characterization by technetium-99m-HMPAO and SPECT
13. Intravenous immunoglobulin treatment of children with autism
14. Biology of Th1 and Th2 cells
15. Functional neuroimaging of autistic disorders. Invited review
16. Differential effects of pentoxifylline on the production of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) by monocytes and T cells
17. Intravenous Immunoglobulin (IVIG) for the therapy of autoimmune disorders
18. Antibodies to myelin basic protein in children with autistic behavior
19. Circulating autoantibodies to neuronal and glial filament protein in autism
20. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children
21. Reduced natural killer cell activity in autism
22. Immune abnormalities in patients with autism
23. Strong association of the third hypervariable region of HLA-DRβ with autism
24. Increased frequency of the null allele at the complement C4b locus in autism
25. Possible association of the extended MHC haplotype B44-SC30-DR4 with autism
26. DR-positive T cells in autism: Association with decreased plasma levels of the complement C4b protein
27. CD4+ Helper T cell depletion in autism